Molecular Diagnostics Market: Current Scenario and Forecast (2019-2025)

Molecular Diagnostics Market: Current Scenario and Forecast (2019-2025)

Emphasis on Product (Reagents, Instruments Services), Techniques (Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays, Others), Application (Microbiology, Virology, Hospital Acquired Infections (HAI), Genetic Testing, Oncology, Pharmacogenetics, Human Leukocytes Antigen (HLA), Blood Screening, Others), End-Users (Hospitals, Clinics & Labs, Other Healthcare Facilities) and Region/Country

$ 3500
$4900
$6860

Published: Dec-2019

Pages:340

Table:116

Figure:216

Report ID:UMHE19196

Global Molecular Diagnostics Market was valued at US$ 6,242.6 million in 2018 and is anticipated to reach US$ 9,546.2 million by 2025 displaying a reasonable CAGR of 6.3% over the forecast period (2019-2025). Molecular Diagnostics is the detection of genomic variants, aiming to facilitate detection, diagnosis, subclassification, prognosis, and monitoring response to therapy. The market of Molecular Diagnostics market is anticipated to grow enormously owing to factors such as rising geriatric population, increasing prevalence of chronic diseases, increasing adoption of Point-of-care diagnosis, advances in genomics and proteomics, and introduction of technologically advanced products. The growing incidence of infectious diseases and cancer is increasing the demand for molecular diagnostics techniques. The rapid advancements witnessed in the molecular biology technologies, development of molecular diagnostic technologies to automated processes, growing awareness about molecular diagnostics usage for the detection of different diseases in developing countries is boosting the overall market growth. The investment in unifying technology, consolidation and automation of labs, and shift to data-driven healthcare will mark as a trend in this industry. However, high prices of molecular diagnostics tests and unfavourable reimbursement policies will act as the major challenges in the growth of this market.

Points of Entry in the Diagnostics Supply Chain

In this evolving environment, it is a business imperative for diagnostic manufacturers to understand, demonstrate, and clearly articulate how their offerings can lead not only to better patient outcomes but also create value for a variety of key stakeholders. There are many ways that diagnostic technologies can impact the quality and cost of care. Medical diagnostic tests and technologies are at the forefront of health care and personalized medicine. These technologies increasingly are a key component in ensuring that the right treatment gets to the right patient at the right time. Advances in life sciences and in test technologies are making diagnostics ever more central in the delivery of effective health care. It is well understood by health care stakeholders that diagnostics significantly affect clinical decision-making. Nevertheless, it is critical for diagnostic test developers to be able to demonstrate the value of their tests to a variety of stakeholders in the face of growing scrutiny and cost pressure directed at almost every health care sector

“Reagents are the majorly used product under the Molecular Diagnostics market, holding ~69% share in 2018”

Based on product type the global molecular diagnostics market is bifurcated into Instruments, Reagents and services and others. The market of the Reagents segment is expected to grow tremendously and is projected to dominate the market in 2025 due to the high demand for over-the-counter diagnostic tests, rise in adoption of these tests in nonmedical facilities, such as home.

“Polymerase chain reaction (PCR) is expected to dominate the technique segment during the analyzed period.”

Molecular diagnostics market, based on technique is segmented into Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays and others. The PCR segment occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025 owing to the increased usage and advancements in PCR techniques.

Molecular Diagnostics Market Size by Technique Type, Global, 2018-2025 (US$ Million)

“Molecular Diagnostic techniques are majorly applied for Virology study, the segment generated revenue of US$ 2,243.9 million in 2018”

The molecular diagnostics market is applied in various medical fields including Microbiology, Virology, Hospital Acquired Infections (HAI), Genetic Testing, Oncology, Pharmacogenetics, Human Leukocytes Antigen (HLA), Blood Screening and others. In 2018, Virology segment dominated the market and is anticipated to dominate this segment in 2025. However, Oncology application segment is expected to witness the highest CAGR growth of 8.27% during the forecast period 2019-2025.

“Amongst end-users’ type, hospitals are anticipated to dominate Global Molecular Diagnostics market by 2025.”

Hospitals, clinics & labs and others are the major end-users of the molecular diagnostic technology. In 2018, the application of the technology was dominated by Hospitals segment. The increased adoption in hospitals is driven by high procedure volume and extensive presence of ancillary support in terms of manpower and infrastructure. However, Clinics & labs application type is expected to witness reasonable CAGR growth during the analyzed period.

“North America dominated the market for molecular diagnostic technology in 2018, followed by Asia-Pacific and Europe”

For a deep-dive analysis of the industry, detailed regional/country-level analysis is conducted for markets including North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World). In 2018, North America generated revenue of US$ 2,964.9 million, however, Asia-Pacific is expected to witness highest CAGR of 6.74% during the forecast period. The dominance of North America is majorly driven by the presence of a well-established diagnostic infrastructure, technological advancements, patient awareness and presence of advanced products in the field of molecular diagnostics.

Competitive Landscape-Top 10 Market Players

Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Hologic, Inc., Qiagen, Roche, Siemens Healthineers AG, Sysmex Corporation and Thermo Fisher Scientific are some of the prominent players operating in the Global Molecular Diagnostics market industry. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.

Reasons to buy:

  • Current and future market size from 2018 to 2025 in terms of value (US$)
  • Combined analysis of deep-dive secondary research and input from primary research through Key Opinion Leaders of the industry
  • Country-level details of the overall adoption of molecular diagnostics market
  • A quick review of overall industry performance at a glance
  • In-depth analysis of key industry players
  • A detailed analysis of regulatory framework, drivers, restraints, key trends and opportunities prevailing in the industry
  • Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start-ups
  • The study comprehensively covers the market across different segments and sub-segments of the technology
  • Regions/countries Covered: North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World)

Customization Options:

UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Molecular Diagnostics Market can be customized to the country level or any other market segment.

 

    1.1 Market Definition  
    1.2 Objective of the Study
    1.3 Limitation      
    1.4 Stakeholders    
    1.5 Currency used in the Report
    1.6 Scope of the Global Molecular Diagnostics Market Study
  2 RESEARCH METHODOLOGY  
    2.1 Research Methodology for Global Molecular Diagnostics (MDx) Market Study
      2.1.1 Main objective of the Global Molecular Diagnostics Market Study
  3 COMPREHENSIVE ASSESSMENT OF THE VALUE OF DIAGNOSTIC TESTS
    3.1 General Overview  
    3.2 Capturing the full spectrum of the value that a diagnostic test contributes
    3.3 Ensuring that robust analyses underpin the value assessment
    3.4 Accounting for variation in diagnostic test types in value assessment methods
    3.5 Aligning on how to define and measure value drivers
      3.5.1 Value Driver: Clinical Impact
      3.5.2 Value Driver: Non-Clinical Patient Impact
      3.5.3 Value Driver: Care Delivery Revenue and Cost Impact
      3.5.4 Value Driver: Public/Population Impact
  4 REFRAMING THE DIAGNOSTICS INDUSTRY
    4.1 General Overview  
  5 EXECUTIVE SUMMARY  
  6 INDUSTRY PERFORMANCE  
  7 RISK MITIGATION    
    7.1 General Overview  
    7.2 Supply Chain    
    7.3 Risk Assessment  
    7.4 Bulk, Custom and Contract Manufacturing
  5 MARKET OVERVIEW    
    5.1 Introduction of Molecular Diagnostics Market
      5.1.1 Essential Components or Attributes of Diagnostics
      5.1.2 Main Categories of Diagnostics
      5.1.3 Settings of Use  
    5.2 Current and Future Use of Diagnostic Products
      5.2.1 Primary Uses of Diagnostics
        5.2.1.1 Predictive Applications/Screening/Early Disease Detection
        5.2.1.2 Diagnostic
        5.2.1.3 Secondary Risk Assessment – Prognostic
        5.2.1.4 Drug Selection/Treatment Targeting
        5.2.1.5 Disease/Condition Monitoring and Management
      5.2.2 Molecular Diagnostics: Overview of Future Trends and Directions
        5.2.2.1 Predict Disease Before Symptoms Appear
        5.2.2.2 Predict Beneficial and Adverse Treatment Effects
        5.2.2.3 Enable Personalized “Real-Time” Treatment and Disease Management Regimens
        5.2.2.4 Facilitate Point-of-care and Near-patient Testing
        5.2.2.5 Enable Home Testing
        5.2.2.6 Public Health, Environmental, Bioterrorism Applications
        5.2.2.7 Technology and Testing System Integration
      5.2.3 The Importance of Molecular Diagnostics
      5.2.4 Market Drivers  
        5.2.4.1 Increasing Prevalence of Chronic Diseases
        5.2.4.2 Rising Geriatric Population
        5.2.4.3 Increasing adoption of Point-of-Care Diagnosis
        5.2.4.4 Technology Advancement in the In-Vitro Diagnostics
        5.2.4.5 Advances in Genomics and Proteomics
      5.2.5 Market Restraints
        5.2.5.1 Unfavorable Reimbursement Policies for In-Vitro Diagnostics
        5.2.5.2 High Prices of Molecular Diagnostics Tests
      5.2.6 Market Opportunities
        5.2.6.1 Increasing Support from Governments and Key Players
        5.2.6.2 Growing Significance of Companion Diagnostics
      5.2.7 Market Trends  
        5.2.7.1 Changing Reimbursement Models and Regulations
        5.2.7.2 Investing in Unifying Technology
        5.2.7.3 Consolidation and Automation of Labs
        5.2.7.4 Shift to Data-Driven Healthcare
        5.2.7.5 Consumer Lab Testing
        5.2.7.6 Healthcare Convergence
  6 REGULATIONS AND REIMBURSEMENT POLICY
    6.1 Regulation    
      6.1.1 United States  
        6.1.1.1 Approval/Clearance of Molecular Diagnostic Instruments
        6.1.1.2 Recommendations for Submissions for Molecular Diagnostic Instruments with Combined Functions
          6.1.1.2.1 New Instruments
          6.1.1.2.2 Existing Approved/Cleared Instruments
          6.1.1.2.3 Submission Information, Labeling, and Marketing
          6.1.1.2.4 Promotion and Labeling Issues
          6.1.1.2.5 Software/Hardware Changes
          6.1.1.2.6 Third-Party Assay Developers
          6.1.1.2.7 MDR Reporting
    6.2 Reimbursement  
  7 KEY MARKET INDICATORS  
    7.1 Demand Side Analysis
      7.1.1 Some of the Key Facts about Aging Population
      7.1.2 Health Conditions Associated with Aging
        7.1.2.1 Some of the key facts about Cardiovascular Diseases (CVD) as per WHO
    7.2 Supply Side Analysis  
      7.2.1 Product Launches
      7.2.2 Partnership  
      7.2.3 Business Expansions and Investments
      7.2.4 Merger and Acquisition
    7.3 SWOT Analysis of Molecular Diagnostics
    7.4 Value Chain Analysis of Molecular Diagnostics
  8 MARKET INSIGHT BY PRODUCT
    8.1 General Overview  
      8.1.1 Reagents    
      8.1.2 Instruments Services
  9 MARKET INSIGHT BY TECHNIQUE
    9.1 General Overview  
      9.1.1 Polymerase chain reaction (PCR)
      9.1.2 Transcription-Mediated Amplification (TMA)
      9.1.3 In Situ Hybridization & FISH
      9.1.4 DNA Sequencing & Next-Generation Sequencing (NGS)
      9.1.5 Case Study: Next Generation Sequencing for Clinical Diagnostics
      9.1.6 Chips and Microarrays
      9.1.7 Others    
  10 MARKET INSIGHT BY APPLICATION
    10.1 General Overview  
      10.1.1 Microbiology  
      10.1.2 Virology    
      10.1.3 Hospital Acquired Infections (HAI)
      10.1.4 Genetic Testing  
      10.1.5 Oncology    
      10.1.6 Pharmacogenetics
      10.1.7 Human Leukocyte Antigen (HLA Testing)
      10.1.8 Blood Screening
      10.1.9 Others    
  11 MARKET INSIGHT BY END USER
    11.1 General Overview  
      11.1.1 Hospitals    
      11.1.2 Clinics & Laboratory
      11.1.3 Others    
  12 MARKET INSIGHT BY REGION
    12.1 General Overview  
      12.2 North America MDx Market Insight
        12.2.1 North America Molecular Diagnostics Market by Product
        12.2.2 North America Molecular Diagnostics Market by Technique
        12.2.3 North America Molecular Diagnostics Market by Application
        12.2.4 North America Molecular Diagnostics Market by End Users
        12.2.5 North America Molecular Diagnostics Market by Country
          12.2.5.1 United States
            12.2.5.1.1 Key Findings on Healthcare Spending in the US, 2017
            12.2.5.1.2 US Health Spending by Type of Service or Product, 2017
            12.2.5.1.3 Health Spending by Major Sources of Funds
            12.2.5.1.4 United States Molecular Diagnostics Market by Product
            12.2.5.1.5 United States Molecular Diagnostics Market by Technique
            12.2.5.1.6 United States Molecular Diagnostics Market by Application
            12.2.5.1.7 United States Molecular Diagnostics Market by End Users
          12.2.5.2 Canada
            12.2.5.2.1 Key Findings on Canada Healthcare Spending, 2018
            12.2.5.2.2 Key Findings on Hospital sector Spending in Canada, 2017
            12.2.5.2.3 Canada Molecular Diagnostics Market by Product
            12.2.5.2.4 Canada Molecular Diagnostics Market by Technique
            12.2.5.2.5 Canada Molecular Diagnostics Market by Application
            12.2.5.2.6 Canada Molecular Diagnostics Market by End Users
          12.2.5.5 Rest of North America
            12.2.5.5.1 Rest of NA Molecular Diagnostics Market by Product
            12.2.5.5.2 Rest of NA Molecular Diagnostics Market by Technique
            12.2.5.5.3 Rest of NA Molecular Diagnostics Market by Application
            12.2.5.5.4 Rest of NA Molecular Diagnostics Market by End Users
    12.3 Europe Molecular Diagnostic Market Insight
      12.3.1 Europe Molecular Diagnostics Market by Product
      12.3.2 Europe Molecular Diagnostics Market by Technique
      12.3.3 Europe Molecular Diagnostics Market by Application
      12.3.4 Europe Molecular Diagnostics Market by End Users
      12.3.5 Europe Molecular Diagnostics Market by Country
        12.3.5.1 Germany  
          12.3.5.1.1 Germany Molecular Diagnostics Market by Product
          12.3.5.1.2 Germany Molecular Diagnostics Market by Technique
          12.3.5.1.3 Germany Molecular Diagnostics Market by Application
          12.3.5.1.4 Germany Molecular Diagnostics Market by End Users
        12.3.5.2 France  
          12.3.5.2.1 France Molecular Diagnostics Market by Product
          12.3.5.2.2 France Molecular Diagnostics Market by Technique
          12.3.5.2.3 France Molecular Diagnostics Market by Application
          12.3.5.2.4 France Molecular Diagnostics Market by End Users
        12.3.5.3 Spain  
          12.3.5.3.1 Spain Molecular Diagnostics Market by Product
          12.3.5.3.2 Spain Molecular Diagnostics Market by Technique
          12.3.5.3.3 Spain Molecular Diagnostics Market by Application
          12.3.5.3.4 Spain Molecular Diagnostics Market by End Users
        12.3.5.4 Italy    
          12.3.5.4.1 Italy Molecular Diagnostics Market by Product
          12.3.5.4.2 Italy Molecular Diagnostics Market by Technique
          12.3.5.4.3 Italy Molecular Diagnostics Market by Application
          12.3.5.4.4 Italy Molecular Diagnostics Market by End Users
        12.3.5.5 United Kingdom
          12.3.5.5.1 United Kingdom Molecular Diagnostics Market by Product
          12.3.5.5.2 United Kingdom Molecular Diagnostics Market by Technique
          12.3.5.5.3 United Kingdom Molecular Diagnostics Market by Application
          12.3.5.5.4 United Kingdom Molecular Diagnostics Market by End Users
        12.3.5.6 Rest of Europe
          12.3.5.6.1 Rest of Europe Molecular Diagnostics Market by Product
          12.3.5.6.2 Rest of Europe Molecular Diagnostics Market by Technique
          12.3.5.6.3 Rest of Europe Molecular Diagnostics Market by Application
          12.3.5.6.4 Rest of Europe Molecular Diagnostics Market by End Users
    12.4 Asia-Pacific Molecular Diagnostics Market Insight
      12.4.1 Asia-Pacific Molecular Diagnostics Market by Product
      12.4.2 Asia-Pacific Molecular Diagnostics Market by Technique
      12.4.3 Asia-Pacific Molecular Diagnostics Market by Application
      12.4.4 Asia-Pacific Molecular Diagnostics Market by End Users
      12.4.5 Asia-Pacific Molecular Diagnostics Market by Country
        12.4.5.1 China  
          12.4.5.1.1 China In-Vitro Diagnostics Services Market
          12.4.5.1.2 China Molecular Diagnostics Market by Product
          12.4.5.1.3 China Molecular Diagnostics Market by Technique
          12.4.5.1.4 China Molecular Diagnostics Market by Application
          12.4.5.1.5 China Molecular Diagnostics Market by End Users
        12.4.5.2 India  
          12.4.5.2.1 India Molecular Diagnostics Market by Product
          12.4.5.2.2 India Molecular Diagnostics Market by Technique
          12.4.5.2.3 India Molecular Diagnostics Market by Application
          12.4.5.2.4 India Molecular Diagnostics Market by End Users
        12.4.5.3 Japan  
          12.4.5.3.1 Japan Molecular Diagnostics Market by Product
          12.4.5.3.2 Japan Molecular Diagnostics Market by Technique
          12.4.5.3.3 Japan Molecular Diagnostics Market by Application
          12.4.5.3.4 Japan Molecular Diagnostics Market by End Users
        12.4.5.4 Australia  
          12.4.5.4.1 Australia Molecular Diagnostics Market by Product
          12.4.5.4.2 Australia Molecular Diagnostics Market by Technique
          12.4.5.4.3 Australia Molecular Diagnostics Market by Application
          12.4.5.4.4 Australia Molecular Diagnostics Market by End Users
        12.4.5.5 Rest of APAC Market Insight
          12.4.5.5.1 Rest of APAC Molecular Diagnostics Market by Product
          12.4.5.5.2 Rest of APAC Molecular Diagnostics Market by Technique
          12.4.5.5.3 Rest of APAC Molecular Diagnostics Market by Application
          12.4.5.5.4 Rest of APAC Molecular Diagnostics Market by End Users
    12.5 Rest of World Market Insight
      12.5.1 Rest of World Molecular Diagnostics Market by Product
      12.5.2 Rest of World Molecular Diagnostics Market by Technique
      12.5.3 Rest of World Molecular Diagnostics Market by Application
      12.5.4 Rest of World Molecular Diagnostics Market by End Users
      12.5.5 Rest of World Molecular Diagnostics Market by Country
        12.5.5.1 Brazil  
          12.5.5.1.1 Brazil Molecular Diagnostics Market by Product
          12.5.5.1.2 Brazil Molecular Diagnostics Market by Technique
          12.5.5.1.3 Brazil Molecular Diagnostics Market by Application
          12.5.5.1.4 Brazil Molecular Diagnostics Market by End Users
        12.5.5.2 Other Rest of World
          12.5.5.2.1 Other Rest of World Molecular Diagnostics Market by Product
          12.5.5.2.2 Other Rest of World Molecular Diagnostics Market by Technique
          12.5.5.2.3 Other Rest of World Molecular Diagnostics Market by Application
          12.5.5.2.4 Other Rest of World Molecular Diagnostics Market by End Users
  13 COMPETITIVE SCENARIO  
    13.1 Porter’s Five forces analysis
      13.1.1 Bargaining Power of Suppliers
      13.1.2 Bargaining Power of Buyers
      13.1.3 Threat of New Entrants
      13.1.4 Threat of Substitutes
      13.1.5 Industry Rivalry  
    13.2 Market Share Analysis, by Company
      13.2.1 Molecular Diagnostics Market Share Analysis by Company 2018
  14 TOP COMPANY PROFILES  
    14.1 Abbott Laboratories  
      14.1.1 Key Facts    
      14.1.2 Business Description
      14.1.3 Key Product/Services Offerings
      14.1.4 Growth Strategy
      14.1.5 SWOT Analysis  
      14.1.6 Key Financials  
        14.1.6.1 Revenue Split
      14.1.7 Recent Developments
        14.1.7.1 Product Launches
        14.1.7.2 Partnership
        14.1.7.3 Merger and Acquisition
    14.2 Becton, Dickinson and Company
      14.2.1 Key Facts    
      14.2.2 Business Description
      14.2.3 Key Product/Services Offerings (AI Technology)
      14.2.4 Growth Strategy
      14.2.5 SWOT Analysis  
      14.2.6 Key Financials  
        14.2.6.1 Revenue Split
      14.2.7 Recent Developments
        14.2.7.1 Product Launches
        14.2.7.2 Business Expansions and Investments
        14.2.7.3 Merger & Acquisitions
    14.3 Biomérieux SA    
      14.3.1 Key Facts    
      14.3.2 Business Description
      14.3.3 Key Product/Services Offerings
      14.3.4 Growth Strategy
      14.3.5 SWOT Analysis  
      14.3.6 Key Financials  
        14.3.6.1 Revenue Split
      14.3.7 Recent Developments
        14.3.7.1 Product Launches
        14.3.7.2 Partnerships
        14.3.7.3 Mergers and Acquisitions
    14.4 Hologic, Inc.    
      14.4.1 Key Facts    
      14.4.2 Business Description
      14.4.3 Key Product/Services Offerings
      14.4.4 Growth Strategy
      14.4.5 SWOT Analysis  
      14.4.6 Key Financials  
        14.4.6.1 Revenue Split
      14.4.7 Recent Developments
        14.4.7.1 Product Launches
        14.4.7.2 Partnerships
        14.4.7.3 Business Expansion & Investment
        14.4.7.4 Mergers and Acquisitions
    14.5 Danaher Corporation  
      14.5.1 Key Facts    
      14.5.2 Business Description
      14.5.3 Key Product/Services Offerings
      14.5.4 Growth Strategy
      14.5.5 SWOT Analysis  
      14.5.6 Key Financials  
        14.5.6.1 Revenue Split
      14.5.7 Recent Developments
        14.5.7.1 Merger and Acquisitions
    14.6 Qiagen      
      14.6.1 Key Facts    
      14.6.2 Business Description
      14.6.3 Key Product/Services Offerings
      14.6.4 Growth Strategy
      14.6.5 Key Milestones  
      14.6.6 SWOT Analysis  
      14.6.7 Key Financials  
        14.6.7.1 Revenue Split
      14.6.8 Recent Developments
        14.6.8.1 Product Launches
        14.6.8.2 Partnerships
        14.6.8.3 Business Expansions and Investment
        14.6.8.4 Mergers and Acquisitions
    14.7 Roche Holding AG  
      14.7.1 Key Facts    
      14.7.2 Business Description
      14.7.3 Key Product/Services Offerings
      14.7.4 Growth Strategy
      14.7.5 SWOT Analysis  
      14.7.6 Key Financials  
        14.7.6.1 Revenue Split
      14.7.7 Recent Developments
        14.7.7.1 Product Launches
        14.7.7.2 Partnership
        14.7.7.3 Mergers and Acquisitions
    14.8 Siemens Healthineers AG
      14.8.1 Key Facts    
      14.8.2 Business Description
      14.8.3 Key Product/Services Offerings
      14.8.4 Growth Strategy
      14.8.5 SWOT Analysis  
      14.8.6 Key Financials  
        14.8.6.1 Revenue Split
      14.8.7 Recent Developments
        14.8.7.1 Product Launches
        14.8.7.2 Partnership
        14.8.7.3 Business Expansion and Investment
        14.8.7.4 Merger and Acquisitions
    14.9 Thermo Fisher Scientific
      14.9.1 Key Facts    
      14.9.2 Business Description
      14.9.3 Key Product/Services Offerings
      14.9.4 Growth Strategy
      14.9.5 SWOT Analysis  
      14.9.6 Key Financials  
        14.9.6.1 Revenue Split
      14.9.7 Recent Developments
        14.9.7.1 Product Launch
        14.9.7.2 Partnerships
        14.9.7.3 Expansion and Investment
        14.9.7.4 Merger and Acquisition
    14.1 Sysmex Corporation  
      14.10.1 Key Facts    
      14.10.2 Business Description
      14.10.3 Key Product/Services Offerings
      14.10.4 Growth Strategy
      14.10.5 SWOT Analysis  
      14.10.6 Key Financials  
        14.10.6.1 Revenue Split
      14.10.7 Recent Developments
        14.10.7.1 Product Launches
        14.10.7.2 Partnership
        14.10.7.3 Business Expansion & Investments
        14.10.7.4 Merger and Acquisitions

Analyzing historical market, estimation of the current market and forecasting the future market for Global Molecular Diagnostics were the three major steps undertaken to create and analyze the overall adoption rate of Molecular Diagnostics services in major regions/countries globally. Exhaustive secondary research was conducted to collect the historical market of the technology and overall estimation of the current market. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the Molecular Diagnostics. Post assumption and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of Molecular Diagnostics market at Global scale. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the current and forecast market size of segments and sub-segments of the technology. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Global Molecular Diagnostics Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records, etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other credible publications. For economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used.

Step 2: Market Segmentation:

After obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments of the Global Molecular Diagnostics. Major segments included in the report are product type, technique, application and end-users. Further detailed regional/country-level analysis was also conducted to analyze the overall penetration rate of the technology    

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments detailed factor analysis was conducted to estimate the current market size of the Global Molecular Diagnostics. Factor analysis was conducted using dependent and independent variables such as accelerating aging population, rising prevalence of age-related disorders and Increasing demand for residential care facilities. Historical trends of the Global Molecular Diagnostics and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply-side scenario were also thoroughly studied.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market drivers, restraints, trends and opportunities available in the market. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments for major regions/countries. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value and rate of adoption of Molecular Diagnostics technique globally
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global Molecular Diagnostics market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarized, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants

Market Engineering

Data triangulation technique was employed to complete the overall market engineering process and to arrive at precise statistical numbers of each segment and sub-segment pertaining to the Global Molecular Diagnostics market. Data was split into several segments post studying various parameters and trends in the areas of product type, technique such as Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization & FISH, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays and applications and regions such as North America, Europe, APAC among others

Main objective of the Global Molecular Diagnostics Market Study

The current & future market trends of the global Molecular Diagnostics market are pinpointed in the study. The investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. The current and future market trends would determine the overall attractiveness of the market, providing a platform for the diagnostics healthcare participant to exploit the untapped market to benefit as the first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the global Molecular Diagnostics market in terms of value (US$) and volume
  • Analyze the current and forecast market size of different segments and sub-segments of the global Molecular Diagnostics market
  • To analyze the revenue and business models of the market players in the industry
  • To understand the initiatives undertaken by diagnostics companies Vs service providers to increase the overall analysis of Molecular Diagnostics in major regions
  • Define and describe the segments and sub-segments considered in the evaluation of the global Molecular Diagnostics market and anticipate potential risk associated with the market
  • Define and analysis of the government regulations for diagnostics
  • Analyze the current and forecast market size of the global Molecular Diagnostics market for major regions/countries including North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World)

Define and analyze the competitive landscape of the global Molecular Diagnostics market and the growth strategies adopted by the market players to sustain in the fast-growing market

 

Analyzing historical market, estimation of the current market and forecasting the future market for Global Molecular Diagnostics were the three major steps undertaken to create and analyze the overall adoption rate of Molecular Diagnostics services in major regions/countries globally. Exhaustive secondary research was conducted to collect the historical market of the technology and overall estimation of the current market. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the Molecular Diagnostics. Post assumption and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of Molecular Diagnostics market at Global scale. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the current and forecast market size of segments and sub-segments of the technology. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Global Molecular Diagnostics Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records, etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other credible publications. For economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used.

Step 2: Market Segmentation:

After obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments of the Global Molecular Diagnostics. Major segments included in the report are product type, technique, application and end-users. Further detailed regional/country-level analysis was also conducted to analyze the overall penetration rate of the technology    

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments detailed factor analysis was conducted to estimate the current market size of the Global Molecular Diagnostics. Factor analysis was conducted using dependent and independent variables such as accelerating aging population, rising prevalence of age-related disorders and Increasing demand for residential care facilities. Historical trends of the Global Molecular Diagnostics and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply-side scenario were also thoroughly studied.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market drivers, restraints, trends and opportunities available in the market. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments for major regions/countries. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value and rate of adoption of Molecular Diagnostics technique globally
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global Molecular Diagnostics market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarized, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants

Market Engineering

Data triangulation technique was employed to complete the overall market engineering process and to arrive at precise statistical numbers of each segment and sub-segment pertaining to the Global Molecular Diagnostics market. Data was split into several segments post studying various parameters and trends in the areas of product type, technique such as Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization & FISH, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays and applications and regions such as North America, Europe, APAC among others

Main objective of the Global Molecular Diagnostics Market Study

The current & future market trends of the global Molecular Diagnostics market are pinpointed in the study. The investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. The current and future market trends would determine the overall attractiveness of the market, providing a platform for the diagnostics healthcare participant to exploit the untapped market to benefit as the first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the global Molecular Diagnostics market in terms of value (US$) and volume
  • Analyze the current and forecast market size of different segments and sub-segments of the global Molecular Diagnostics market
  • To analyze the revenue and business models of the market players in the industry
  • To understand the initiatives undertaken by diagnostics companies Vs service providers to increase the overall analysis of Molecular Diagnostics in major regions
  • Define and describe the segments and sub-segments considered in the evaluation of the global Molecular Diagnostics market and anticipate potential risk associated with the market
  • Define and analysis of the government regulations for diagnostics
  • Analyze the current and forecast market size of the global Molecular Diagnostics market for major regions/countries including North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World)

Define and analyze the competitive landscape of the global Molecular Diagnostics market and the growth strategies adopted by the market players to sustain in the fast-growing market

 


Molecular Diagnostics Market: Current Scenario and Forecast (2019-2025)